Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 22, Pages 10554-10564
Publisher
Wiley
Online
2021-10-11
DOI
10.1111/jcmm.16986
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Umbilical cord mesenchymal stem cells for COVID ‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
- (2021) Giacomo Lanzoni et al. Stem Cells Translational Medicine
- Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
- (2021) Dipayan Chaudhuri et al. INTENSIVE CARE MEDICINE
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Care for Critically Ill Patients With COVID-19
- (2020) Srinivas Murthy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Cell‐based therapy to reduce mortality from COVID ‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
- (2020) Wenchun Qu et al. Stem Cells Translational Medicine
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
- (2020) Guido Moll et al. Frontiers in Immunology
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts
- (2020) Jin Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Association Between Hypoxemia and Mortality in Patients With COVID-19
- (2020) Jiang Xie et al. MAYO CLINIC PROCEEDINGS
- Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
- (2020) Syed Shahzad Hasan et al. Expert Review of Respiratory Medicine
- Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match
- (2020) Jayeeta Giri et al. Blood Advances
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
- (2020) Feng Lin et al. World Journal of Stem Cells
- Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
- (2019) Henry Caplan et al. Frontiers in Immunology
- Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
- (2019) Behnam Sadeghi et al. Frontiers in Immunology
- Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation
- (2018) Wictor Aronsson-Kurttila et al. ACTA HAEMATOLOGICA
- Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
- (2018) Olle Ringden et al. Stem Cells Translational Medicine
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
- (2017) Arjang Baygan et al. Frontiers in Immunology
- Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients
- (2015) Helen Kaipe et al. STEM CELLS AND DEVELOPMENT
- Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua
- (2015) Guido Moll et al. STEM CELLS AND DEVELOPMENT
- Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
- (2014) Guoping Zheng et al. RESPIRATORY RESEARCH
- Decidual Stromal Cells Promote Regulatory T Cells and Suppress Alloreactivity in a Cell Contact-Dependent Manner
- (2013) Tom Erkers et al. STEM CELLS AND DEVELOPMENT
- The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment
- (2011) Michael A. Matthay et al. Annual Review of Pathology-Mechanisms of Disease
- Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro
- (2011) H. Karlsson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now